ConductScience.org, home

Paper39585482

Therapeutic effect of total glucosides of paeony on IgA vasculitis nephritis: progress and prospects.

Wang Z and 9 others. Mol Biol Rep, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic effect of total glucosides of paeony on IgA vasculitis nephritis: progress and prospects. Papers, record 39585482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39585482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic effect of total glucosides of paeony on IgA vasculitis nephritis: progress and prospects.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.8, provisional
iCite
Revised in PubMed
2025-12-27
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang ZZhifeng
2Yang JJiao
3He PPengfen
4Lan JJunfeng
5Shi TTing
6Xu SShuangfeng
7Hao ZZhihui
8Xi YYujiang
9Wang JJian
10He PPing

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucosidesMajor topic
PaeoniaMajor topic
Humans
Animals
IgA Vasculitis
Immunoglobulin A
Glomerulonephritis, IGA
Vasculitis
Nephritis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82160922National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130879080European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.Rheumatology (Oxford)2019https://conductscience.org/library/papers/30879080PubMed
236739540Demographic and clinical features of pediatric vasculitis: a single-center study.ARP Rheumatol2023https://conductscience.org/library/papers/36739540PubMed
332384035Henoch-Schönlein Purpura in Children: An Updated Review.Curr Pediatr Rev2020https://conductscience.org/library/papers/32384035PubMed
436915829Diagnostic and Management Strategies of IgA Vasculitis Nephritis/Henoch-Schönlein Purpura Nephritis in Pediatric Patients: Current Perspectives.Pediatric Health Med Ther2023https://conductscience.org/library/papers/36915829PubMed
524134307Henoch-Schönlein purpura in children.J Paediatr Child Health2013https://conductscience.org/library/papers/24134307PubMed
637904705Combined use of total glucosides of paeony and hydroxychloroquine in primary Sjögren's syndrome: A systematic review.Immun Inflamm Dis2023https://conductscience.org/library/papers/37904705PubMed
737402434Efficacy and safety of total glucosides of paeony in the treatment of 5 types of inflammatory arthritis: A systematic review and meta-analysis.Pharmacol Res2023https://conductscience.org/library/papers/37402434PubMed
831836457Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony.Pharmacol Ther2020https://conductscience.org/library/papers/31836457PubMed
924325071[Progress of pharmacological actions of total glucosides of paeony in treating diabetic nephropathy].Zhongguo Zhong Xi Yi Jie He Za Zhi2013https://conductscience.org/library/papers/24325071PubMed
1030949054Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin.Front Pharmacol2019https://conductscience.org/library/papers/30949054PubMed
1133305640Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin.Drug Dev Ind Pharm2021https://conductscience.org/library/papers/33305640PubMed
1232989282WNT-β-catenin signalling - a versatile player in kidney injury and repair.Nat Rev Nephrol2021https://conductscience.org/library/papers/32989282PubMed
1323247788[Predictive factors of severe Henoch-Schonlein nephritis in children: report of 34 cases].Tunis Med2012https://conductscience.org/library/papers/23247788PubMed
1434483931Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis.Front Pharmacol2021https://conductscience.org/library/papers/34483931PubMed
1524269653
β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Cell Signal2014https://conductscience.org/library/papers/24269653PubMed
1621350016Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development.Development2011https://conductscience.org/library/papers/21350016PubMed
1725803581Stromally expressed β-catenin modulates Wnt9b signaling in the ureteric epithelium.PLoS One2015https://conductscience.org/library/papers/25803581PubMed
1825612449[Effect of total glucosides of paeony on Wnt/β-catenin signal transduction pathway expression in kidney of diabetic rats].Zhongguo Zhong Yao Za Zhi2014https://conductscience.org/library/papers/25612449PubMed
1932393431Total glucosides of paeony (Paeonia lactiflora) alleviates blood-brain barrier disruption and cerebral ischemia/reperfusion injury in rats via suppressing inflammation and apoptosis.Pharmazie2020https://conductscience.org/library/papers/32393431PubMed
2029694958Current Mechanistic Concepts in Ischemia and Reperfusion Injury.Cell Physiol Biochem2018https://conductscience.org/library/papers/29694958PubMed

See all 55 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42634806Network Pharmacology-Metabolomics Integration Reveals the Multiple Targets and Mechanisms of Total Glucosides of Paeony Against Ulcerative Colitis.J Inflamm Res2026https://conductscience.org/library/papers/42634806PubMed
40354007Feasibility analysis and development trend of nanomaterials for the treatment of pancreatic cancer.Discov Nano2025https://conductscience.org/library/papers/40354007PubMed
40241343Paeoniflorin Protects Retinal Pigment Epithelial Cells from High Glucose-Induced Oxidative Damage by Activating Nrf2-Mediated HO-1 Signaling.Biomol Ther (Seoul)2025https://conductscience.org/library/papers/40241343PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39585482

GET https://conductscience.org/api/papers/v1/39585482/references?page=2